![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 3, 1897-1905, January 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the § Massey Cancer Center and Departments of
Internal Medicine and Human Genetics, Virginia Commonwealth University,
Richmond, Virginia 23298-0037 and The methylation pattern of a 248-base pair
proximal transcribed region (
Department of Medicine,
Overton Brooks Veterans Affairs Medical Center and Feist-Weiller Cancer
Center, Louisiana State University Health Sciences Center,
Shreveport, Louisiana 71101-4295
248) of the avian embryonic
-globin
gene was found to correlate inversely with stage-specific expression in
avian erythroid cells. In vitro methylation of the
248
segment alone (in the absence of promoter methylation) resulted in a
5-fold inhibition of transcription in a transient transfection assay in
primary erythroid cells in which the transfected gene is packaged into
nucleosomal chromatin. This effect was observed if the
248 segment
was positioned adjacent to the promoter but not when it was located 2.7 kilobases downstream. Fully methylated but not unmethylated
248
formed a novel cell type-specific methyl
cytosine-binding protein complex
(MeCPC) that contained methyl binding
domain protein-2 (MBD-2) and histone deacetylase 1 proteins but differed from MeCP-1. The histone deacetylase inhibitor
trichostatin A failed to relieve methylation-mediated repression of
transcription from the
-gene promoter, supporting the notion of the
dominance of methylation over histone deacetylation in silencing
through CpG-rich sequences at this locus. These data demonstrate that
site-specific methylation of a vertebrate gene 5'-transcribed region
alone at the exact CpGs that are methylated in vivo can
suppress transcription in homologous primary cells and facilitate
binding to a cell type-specific MeCPC.
This article has been cited by other articles:
![]() |
E. P. Kransdorf, S. Z. Wang, S. Z. Zhu, T. B. Langston, J. W. Rupon, and G. D. Ginder MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells Blood, October 15, 2006; 108(8): 2836 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rupon, S. Z. Wang, K. Gaensler, J. Lloyd, and G. D. Ginder Methyl binding domain protein 2 mediates {gamma}-globin gene silencing in adult human betaYAC transgenic mice PNAS, April 25, 2006; 103(17): 6617 - 6622. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Zerbini and T. A. Libermann GADD45 Deregulation in Cancer: Frequently Methylated Tumor Suppressors and Potential Therapeutic Targets Clin. Cancer Res., September 15, 2005; 11(18): 6409 - 6413. [Full Text] [PDF] |
||||
![]() |
P. M. Das and R. Singal DNA Methylation and Cancer J. Clin. Oncol., November 15, 2004; 22(22): 4632 - 4642. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abdollahi, D. Pisarcik, D. Roberts, J. Weinstein, P. Cairns, and T. C. Hamilton LOT1 (PLAGL1/ZAC1), the Candidate Tumor Suppressor Gene at Chromosome 6q24-25, Is Epigenetically Regulated in Cancer J. Biol. Chem., February 14, 2003; 278(8): 6041 - 6049. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singal, J. M. vanWert, and L. Ferdinand Jr Methylation of alpha -type embryonic globin gene alpha pi represses transcription in primary erythroid cells Blood, December 1, 2002; 100(12): 4217 - 4222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |